PMC6556259_01
Clinical course of patient. VP-16: etoposide; CY: cyclophosphamide; TBI: total body irradiation; MTX: methotrexate; G-CSF: granular-colony stimulating factor; mPSL: methylprednisolone; PSL: predonisolone; MMF: mycophenolate mofetil.
CRIT2019-7890673.001.jpg
PMC6556259_01_CRIT2019-7890673.001.jpg
fig1
The clinical course summary after HSCT is shown in Figure 1.
Colonoscopy image at ascending colon (a), at sigmoid colon (b), and at rectum (c). H-E staining x100 of biopsy specimen (d). Apoptotic bodies (arrows) at x400 (e). Edematous surface and scattered erosion were observed at whole colon and rectum. (a~c) Desquamated epithelium, interstitial edema, and submucosal fibrosis were seen as a result of inflammation. (d) Enlarged image showed submucosal lymphocyte infiltration and apoptotic bodies. There were no inclusion body cells (e).
CRIT2019-7890673.002.jpg
PMC6556259_01_CRIT2019-7890673.002.jpg
fig2
There were no cells with inclusion body formation (Figure 2).